picotamide has been researched along with malondialdehyde in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cattaneo, M; Lecchi, A; Mannucci, PM; Tenconi, PM | 1 |
| Berrettini, M; De Cunto, M; Grasselli, S; Nenci, GG; Parise, P | 1 |
| Berrettini, M; De Cunto, M; Nenci, GG; Orzalesi, G; Romanelli, A; Volpato, I | 1 |
3 other study(ies) available for picotamide and malondialdehyde
| Article | Year |
|---|---|
In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Arachidonic Acid; Aspirin; Blood Platelets; Collagen; Drug Interactions; Female; Humans; Male; Malondialdehyde; Phthalic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Sulfonamides; Thromboxane B2 | 1991 |
"In vitro" and "ex vivo" effects of picotamide, a combined thromboxane A2-synthase inhibitor and -receptor antagonist, on human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Cyclic AMP; Dose-Response Relationship, Drug; Female; Humans; Male; Malondialdehyde; Phthalic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane B2; Thromboxane-A Synthase | 1990 |
[In vitro study of the mechanism of the platelet anti-aggregant action of picotamide (G 137)].
Topics: Arachidonic Acid; Aspirin; Blood Platelets; Humans; Malondialdehyde; Molecular Structure; Phthalic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Structure-Activity Relationship; Thromboxane A2; Thromboxane-A Synthase | 1983 |